Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use. LPI (LP Information)' newest research report, the “Stem Cell Therapy Industry Forecast” looks at past sales and reviews total world Stem Cell Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Stem Cell Therapy sales for 2023 through 2029. With Stem Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Stem Cell Therapy industry. This Insight Report provides a comprehensive analysis of the global Stem Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Stem Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Stem Cell Therapy market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Stem Cell Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Stem Cell Therapy. The global Stem Cell Therapy market size is projected to grow from US$ 469.1 million in 2022 to US$ 1724 million in 2029; it is expected to grow at a CAGR of 20.4% from 2023 to 2029. North America is the largest Stem Cell Therapy market with about 65% market share. Europe is follower, accounting for about 16% market share. The key players are Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell, Medi-post, Anterogen, Molmed, Takeda (TiGenix) etc. Top 3 companies occupied about 38% market share. This report presents a comprehensive overview, market shares, and growth opportunities of Stem Cell Therapy market by product type, application, key players and key regions and countries. Market Segmentation: Segmentation by type Autologous Allogeneic Segmentation by application Musculoskeletal Disorder Wounds & Injuries Cornea Cardiovascular Diseases Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Osiris Therapeutics NuVasive Chiesi Pharmaceuticals JCR Pharmaceutical Pharmicell Medi-post Anterogen Molmed Takeda (TiGenix)
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Stem Cell Therapy Market Size 2018-2029 2.1.2 Stem
